Global Short Bowel Syndrome (SBS) Drugs Market Growth 2025-2031
The global Short Bowel Syndrome (SBS) Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Short Bowel Syndrome (SBS) Drugs Industry Forecast” looks at past sales and reviews total world Short Bowel Syndrome (SBS) Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Short Bowel Syndrome (SBS) Drugs sales for 2025 through 2031. With Short Bowel Syndrome (SBS) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Short Bowel Syndrome (SBS) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Short Bowel Syndrome (SBS) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Short Bowel Syndrome (SBS) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Short Bowel Syndrome (SBS) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Short Bowel Syndrome (SBS) Drugs and breaks down the forecast by Type, by Sale Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Short Bowel Syndrome (SBS) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Short Bowel Syndrome (SBS) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Short Bowel Syndrome (SBS) Drugs market?
What factors are driving Short Bowel Syndrome (SBS) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Short Bowel Syndrome (SBS) Drugs market opportunities vary by end market size?
How does Short Bowel Syndrome (SBS) Drugs break out by Type, by Sale Channel?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Short Bowel Syndrome (SBS) Drugs Industry Forecast” looks at past sales and reviews total world Short Bowel Syndrome (SBS) Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Short Bowel Syndrome (SBS) Drugs sales for 2025 through 2031. With Short Bowel Syndrome (SBS) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Short Bowel Syndrome (SBS) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Short Bowel Syndrome (SBS) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Short Bowel Syndrome (SBS) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Short Bowel Syndrome (SBS) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Short Bowel Syndrome (SBS) Drugs and breaks down the forecast by Type, by Sale Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Short Bowel Syndrome (SBS) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Short Bowel Syndrome (SBS) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Glucagon-Like Peptide-2 (GLP-2)
- Growth Hormone
- Glutamine
- Other
- Hospitals
- Clinics
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Takeda
- Emmaus Medical
- Ardelyx
- Naia Pharmaceuticals
- Nutrinia
- OxThera
- Sancilio Pharmaceuticals
- Zealand Pharma
What is the 10-year outlook for the global Short Bowel Syndrome (SBS) Drugs market?
What factors are driving Short Bowel Syndrome (SBS) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Short Bowel Syndrome (SBS) Drugs market opportunities vary by end market size?
How does Short Bowel Syndrome (SBS) Drugs break out by Type, by Sale Channel?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Women's Bicycle Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Women's Bicycle by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Women's Bicycle by Country/Region, 2020, 2024 & 2031
2.2 Women's Bicycle Segment by Type
2.2.1 Low Range
2.2.2 Mid Range
2.2.3 Premium Range
2.3 Women's Bicycle Sales by Type
2.3.1 Global Women's Bicycle Sales Market Share by Type (2020-2025)
2.3.2 Global Women's Bicycle Revenue and Market Share by Type (2020-2025)
2.3.3 Global Women's Bicycle Sale Price by Type (2020-2025)
2.4 Women's Bicycle Segment by Application
2.4.1 Household
2.4.2 Commercial
2.5 Women's Bicycle Sales by Application
2.5.1 Global Women's Bicycle Sale Market Share by Application (2020-2025)
2.5.2 Global Women's Bicycle Revenue and Market Share by Application (2020-2025)
2.5.3 Global Women's Bicycle Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Women's Bicycle Breakdown Data by Company
3.1.1 Global Women's Bicycle Annual Sales by Company (2020-2025)
3.1.2 Global Women's Bicycle Sales Market Share by Company (2020-2025)
3.2 Global Women's Bicycle Annual Revenue by Company (2020-2025)
3.2.1 Global Women's Bicycle Revenue by Company (2020-2025)
3.2.2 Global Women's Bicycle Revenue Market Share by Company (2020-2025)
3.3 Global Women's Bicycle Sale Price by Company
3.4 Key Manufacturers Women's Bicycle Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Women's Bicycle Product Location Distribution
3.4.2 Players Women's Bicycle Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR WOMEN'S BICYCLE BY GEOGRAPHIC REGION
4.1 World Historic Women's Bicycle Market Size by Geographic Region (2020-2025)
4.1.1 Global Women's Bicycle Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Women's Bicycle Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Women's Bicycle Market Size by Country/Region (2020-2025)
4.2.1 Global Women's Bicycle Annual Sales by Country/Region (2020-2025)
4.2.2 Global Women's Bicycle Annual Revenue by Country/Region (2020-2025)
4.3 Americas Women's Bicycle Sales Growth
4.4 APAC Women's Bicycle Sales Growth
4.5 Europe Women's Bicycle Sales Growth
4.6 Middle East & Africa Women's Bicycle Sales Growth
5 AMERICAS
5.1 Americas Women's Bicycle Sales by Country
5.1.1 Americas Women's Bicycle Sales by Country (2020-2025)
5.1.2 Americas Women's Bicycle Revenue by Country (2020-2025)
5.2 Americas Women's Bicycle Sales by Type (2020-2025)
5.3 Americas Women's Bicycle Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Women's Bicycle Sales by Region
6.1.1 APAC Women's Bicycle Sales by Region (2020-2025)
6.1.2 APAC Women's Bicycle Revenue by Region (2020-2025)
6.2 APAC Women's Bicycle Sales by Type (2020-2025)
6.3 APAC Women's Bicycle Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Women's Bicycle by Country
7.1.1 Europe Women's Bicycle Sales by Country (2020-2025)
7.1.2 Europe Women's Bicycle Revenue by Country (2020-2025)
7.2 Europe Women's Bicycle Sales by Type (2020-2025)
7.3 Europe Women's Bicycle Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Women's Bicycle by Country
8.1.1 Middle East & Africa Women's Bicycle Sales by Country (2020-2025)
8.1.2 Middle East & Africa Women's Bicycle Revenue by Country (2020-2025)
8.2 Middle East & Africa Women's Bicycle Sales by Type (2020-2025)
8.3 Middle East & Africa Women's Bicycle Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Women's Bicycle
10.3 Manufacturing Process Analysis of Women's Bicycle
10.4 Industry Chain Structure of Women's Bicycle
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Women's Bicycle Distributors
11.3 Women's Bicycle Customer
12 WORLD FORECAST REVIEW FOR WOMEN'S BICYCLE BY GEOGRAPHIC REGION
12.1 Global Women's Bicycle Market Size Forecast by Region
12.1.1 Global Women's Bicycle Forecast by Region (2026-2031)
12.1.2 Global Women's Bicycle Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Women's Bicycle Forecast by Type (2026-2031)
12.7 Global Women's Bicycle Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Giant Bicycles
13.1.1 Giant Bicycles Company Information
13.1.2 Giant Bicycles Women's Bicycle Product Portfolios and Specifications
13.1.3 Giant Bicycles Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Giant Bicycles Main Business Overview
13.1.5 Giant Bicycles Latest Developments
13.2 Trek Bikes
13.2.1 Trek Bikes Company Information
13.2.2 Trek Bikes Women's Bicycle Product Portfolios and Specifications
13.2.3 Trek Bikes Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Trek Bikes Main Business Overview
13.2.5 Trek Bikes Latest Developments
13.3 Dorel Industries
13.3.1 Dorel Industries Company Information
13.3.2 Dorel Industries Women's Bicycle Product Portfolios and Specifications
13.3.3 Dorel Industries Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Dorel Industries Main Business Overview
13.3.5 Dorel Industries Latest Developments
13.4 Atlas Cycles
13.4.1 Atlas Cycles Company Information
13.4.2 Atlas Cycles Women's Bicycle Product Portfolios and Specifications
13.4.3 Atlas Cycles Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Atlas Cycles Main Business Overview
13.4.5 Atlas Cycles Latest Developments
13.5 Accell Group
13.5.1 Accell Group Company Information
13.5.2 Accell Group Women's Bicycle Product Portfolios and Specifications
13.5.3 Accell Group Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Accell Group Main Business Overview
13.5.5 Accell Group Latest Developments
13.6 Merida
13.6.1 Merida Company Information
13.6.2 Merida Women's Bicycle Product Portfolios and Specifications
13.6.3 Merida Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merida Main Business Overview
13.6.5 Merida Latest Developments
13.7 Halfords (Boardman Bikes)
13.7.1 Halfords (Boardman Bikes) Company Information
13.7.2 Halfords (Boardman Bikes) Women's Bicycle Product Portfolios and Specifications
13.7.3 Halfords (Boardman Bikes) Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Halfords (Boardman Bikes) Main Business Overview
13.7.5 Halfords (Boardman Bikes) Latest Developments
13.8 Samchuly Bicycle
13.8.1 Samchuly Bicycle Company Information
13.8.2 Samchuly Bicycle Women's Bicycle Product Portfolios and Specifications
13.8.3 Samchuly Bicycle Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Samchuly Bicycle Main Business Overview
13.8.5 Samchuly Bicycle Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Women's Bicycle Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Women's Bicycle by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Women's Bicycle by Country/Region, 2020, 2024 & 2031
2.2 Women's Bicycle Segment by Type
2.2.1 Low Range
2.2.2 Mid Range
2.2.3 Premium Range
2.3 Women's Bicycle Sales by Type
2.3.1 Global Women's Bicycle Sales Market Share by Type (2020-2025)
2.3.2 Global Women's Bicycle Revenue and Market Share by Type (2020-2025)
2.3.3 Global Women's Bicycle Sale Price by Type (2020-2025)
2.4 Women's Bicycle Segment by Application
2.4.1 Household
2.4.2 Commercial
2.5 Women's Bicycle Sales by Application
2.5.1 Global Women's Bicycle Sale Market Share by Application (2020-2025)
2.5.2 Global Women's Bicycle Revenue and Market Share by Application (2020-2025)
2.5.3 Global Women's Bicycle Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Women's Bicycle Breakdown Data by Company
3.1.1 Global Women's Bicycle Annual Sales by Company (2020-2025)
3.1.2 Global Women's Bicycle Sales Market Share by Company (2020-2025)
3.2 Global Women's Bicycle Annual Revenue by Company (2020-2025)
3.2.1 Global Women's Bicycle Revenue by Company (2020-2025)
3.2.2 Global Women's Bicycle Revenue Market Share by Company (2020-2025)
3.3 Global Women's Bicycle Sale Price by Company
3.4 Key Manufacturers Women's Bicycle Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Women's Bicycle Product Location Distribution
3.4.2 Players Women's Bicycle Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR WOMEN'S BICYCLE BY GEOGRAPHIC REGION
4.1 World Historic Women's Bicycle Market Size by Geographic Region (2020-2025)
4.1.1 Global Women's Bicycle Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Women's Bicycle Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Women's Bicycle Market Size by Country/Region (2020-2025)
4.2.1 Global Women's Bicycle Annual Sales by Country/Region (2020-2025)
4.2.2 Global Women's Bicycle Annual Revenue by Country/Region (2020-2025)
4.3 Americas Women's Bicycle Sales Growth
4.4 APAC Women's Bicycle Sales Growth
4.5 Europe Women's Bicycle Sales Growth
4.6 Middle East & Africa Women's Bicycle Sales Growth
5 AMERICAS
5.1 Americas Women's Bicycle Sales by Country
5.1.1 Americas Women's Bicycle Sales by Country (2020-2025)
5.1.2 Americas Women's Bicycle Revenue by Country (2020-2025)
5.2 Americas Women's Bicycle Sales by Type (2020-2025)
5.3 Americas Women's Bicycle Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Women's Bicycle Sales by Region
6.1.1 APAC Women's Bicycle Sales by Region (2020-2025)
6.1.2 APAC Women's Bicycle Revenue by Region (2020-2025)
6.2 APAC Women's Bicycle Sales by Type (2020-2025)
6.3 APAC Women's Bicycle Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Women's Bicycle by Country
7.1.1 Europe Women's Bicycle Sales by Country (2020-2025)
7.1.2 Europe Women's Bicycle Revenue by Country (2020-2025)
7.2 Europe Women's Bicycle Sales by Type (2020-2025)
7.3 Europe Women's Bicycle Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Women's Bicycle by Country
8.1.1 Middle East & Africa Women's Bicycle Sales by Country (2020-2025)
8.1.2 Middle East & Africa Women's Bicycle Revenue by Country (2020-2025)
8.2 Middle East & Africa Women's Bicycle Sales by Type (2020-2025)
8.3 Middle East & Africa Women's Bicycle Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Women's Bicycle
10.3 Manufacturing Process Analysis of Women's Bicycle
10.4 Industry Chain Structure of Women's Bicycle
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Women's Bicycle Distributors
11.3 Women's Bicycle Customer
12 WORLD FORECAST REVIEW FOR WOMEN'S BICYCLE BY GEOGRAPHIC REGION
12.1 Global Women's Bicycle Market Size Forecast by Region
12.1.1 Global Women's Bicycle Forecast by Region (2026-2031)
12.1.2 Global Women's Bicycle Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Women's Bicycle Forecast by Type (2026-2031)
12.7 Global Women's Bicycle Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Giant Bicycles
13.1.1 Giant Bicycles Company Information
13.1.2 Giant Bicycles Women's Bicycle Product Portfolios and Specifications
13.1.3 Giant Bicycles Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Giant Bicycles Main Business Overview
13.1.5 Giant Bicycles Latest Developments
13.2 Trek Bikes
13.2.1 Trek Bikes Company Information
13.2.2 Trek Bikes Women's Bicycle Product Portfolios and Specifications
13.2.3 Trek Bikes Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Trek Bikes Main Business Overview
13.2.5 Trek Bikes Latest Developments
13.3 Dorel Industries
13.3.1 Dorel Industries Company Information
13.3.2 Dorel Industries Women's Bicycle Product Portfolios and Specifications
13.3.3 Dorel Industries Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Dorel Industries Main Business Overview
13.3.5 Dorel Industries Latest Developments
13.4 Atlas Cycles
13.4.1 Atlas Cycles Company Information
13.4.2 Atlas Cycles Women's Bicycle Product Portfolios and Specifications
13.4.3 Atlas Cycles Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Atlas Cycles Main Business Overview
13.4.5 Atlas Cycles Latest Developments
13.5 Accell Group
13.5.1 Accell Group Company Information
13.5.2 Accell Group Women's Bicycle Product Portfolios and Specifications
13.5.3 Accell Group Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Accell Group Main Business Overview
13.5.5 Accell Group Latest Developments
13.6 Merida
13.6.1 Merida Company Information
13.6.2 Merida Women's Bicycle Product Portfolios and Specifications
13.6.3 Merida Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merida Main Business Overview
13.6.5 Merida Latest Developments
13.7 Halfords (Boardman Bikes)
13.7.1 Halfords (Boardman Bikes) Company Information
13.7.2 Halfords (Boardman Bikes) Women's Bicycle Product Portfolios and Specifications
13.7.3 Halfords (Boardman Bikes) Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Halfords (Boardman Bikes) Main Business Overview
13.7.5 Halfords (Boardman Bikes) Latest Developments
13.8 Samchuly Bicycle
13.8.1 Samchuly Bicycle Company Information
13.8.2 Samchuly Bicycle Women's Bicycle Product Portfolios and Specifications
13.8.3 Samchuly Bicycle Women's Bicycle Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Samchuly Bicycle Main Business Overview
13.8.5 Samchuly Bicycle Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Short Bowel Syndrome (SBS) Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Short Bowel Syndrome (SBS) Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Glucagon-Like Peptide-2 (GLP-2)
Table 4. Major Players of Growth Hormone
Table 5. Major Players of Glutamine
Table 6. Major Players of Other
Table 7. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Short Bowel Syndrome (SBS) Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Short Bowel Syndrome (SBS) Drugs Sale by Sale Channel (2020-2025) & (K Pcs)
Table 13. Global Short Bowel Syndrome (SBS) Drugs Sale Market Share by Sale Channel (2020-2025)
Table 14. Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2025) & ($ million)
Table 15. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2025)
Table 16. Global Short Bowel Syndrome (SBS) Drugs Sale Price by Sale Channel (2020-2025) & (USD/Pcs)
Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Short Bowel Syndrome (SBS) Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Short Bowel Syndrome (SBS) Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Short Bowel Syndrome (SBS) Drugs Producing Area Distribution and Sales Area
Table 23. Players Short Bowel Syndrome (SBS) Drugs Products Offered
Table 24. Short Bowel Syndrome (SBS) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Short Bowel Syndrome (SBS) Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Short Bowel Syndrome (SBS) Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Short Bowel Syndrome (SBS) Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Short Bowel Syndrome (SBS) Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 40. APAC Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 45. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome (SBS) Drugs
Table 54. Key Market Challenges & Risks of Short Bowel Syndrome (SBS) Drugs
Table 55. Key Industry Trends of Short Bowel Syndrome (SBS) Drugs
Table 56. Short Bowel Syndrome (SBS) Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 59. Short Bowel Syndrome (SBS) Drugs Customer List
Table 60. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Short Bowel Syndrome (SBS) Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Short Bowel Syndrome (SBS) Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Short Bowel Syndrome (SBS) Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Sale Channel (2026-2031) & (K Pcs)
Table 73. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Sale Channel (2026-2031) & ($ millions)
Table 74. Merck Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Merck Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 76. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Merck Main Business
Table 78. Merck Latest Developments
Table 79. Takeda Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 81. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Takeda Main Business
Table 83. Takeda Latest Developments
Table 84. Emmaus Medical Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 86. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Emmaus Medical Main Business
Table 88. Emmaus Medical Latest Developments
Table 89. Ardelyx Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 91. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Ardelyx Main Business
Table 93. Ardelyx Latest Developments
Table 94. Naia Pharmaceuticals Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 96. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Naia Pharmaceuticals Main Business
Table 98. Naia Pharmaceuticals Latest Developments
Table 99. Nutrinia Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 101. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Nutrinia Main Business
Table 103. Nutrinia Latest Developments
Table 104. OxThera Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 106. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. OxThera Main Business
Table 108. OxThera Latest Developments
Table 109. Sancilio Pharmaceuticals Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 111. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Sancilio Pharmaceuticals Main Business
Table 113. Sancilio Pharmaceuticals Latest Developments
Table 114. Zealand Pharma Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 116. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Zealand Pharma Main Business
Table 118. Zealand Pharma Latest Developments
Table 1. Short Bowel Syndrome (SBS) Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Short Bowel Syndrome (SBS) Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Glucagon-Like Peptide-2 (GLP-2)
Table 4. Major Players of Growth Hormone
Table 5. Major Players of Glutamine
Table 6. Major Players of Other
Table 7. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Short Bowel Syndrome (SBS) Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Short Bowel Syndrome (SBS) Drugs Sale by Sale Channel (2020-2025) & (K Pcs)
Table 13. Global Short Bowel Syndrome (SBS) Drugs Sale Market Share by Sale Channel (2020-2025)
Table 14. Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2025) & ($ million)
Table 15. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2025)
Table 16. Global Short Bowel Syndrome (SBS) Drugs Sale Price by Sale Channel (2020-2025) & (USD/Pcs)
Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Short Bowel Syndrome (SBS) Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Short Bowel Syndrome (SBS) Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Short Bowel Syndrome (SBS) Drugs Producing Area Distribution and Sales Area
Table 23. Players Short Bowel Syndrome (SBS) Drugs Products Offered
Table 24. Short Bowel Syndrome (SBS) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Short Bowel Syndrome (SBS) Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Short Bowel Syndrome (SBS) Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Short Bowel Syndrome (SBS) Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Short Bowel Syndrome (SBS) Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 40. APAC Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 45. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome (SBS) Drugs
Table 54. Key Market Challenges & Risks of Short Bowel Syndrome (SBS) Drugs
Table 55. Key Industry Trends of Short Bowel Syndrome (SBS) Drugs
Table 56. Short Bowel Syndrome (SBS) Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 59. Short Bowel Syndrome (SBS) Drugs Customer List
Table 60. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Short Bowel Syndrome (SBS) Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Short Bowel Syndrome (SBS) Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Short Bowel Syndrome (SBS) Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Sale Channel (2026-2031) & (K Pcs)
Table 73. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Sale Channel (2026-2031) & ($ millions)
Table 74. Merck Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Merck Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 76. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. Merck Main Business
Table 78. Merck Latest Developments
Table 79. Takeda Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 81. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Takeda Main Business
Table 83. Takeda Latest Developments
Table 84. Emmaus Medical Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 86. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Emmaus Medical Main Business
Table 88. Emmaus Medical Latest Developments
Table 89. Ardelyx Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 91. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Ardelyx Main Business
Table 93. Ardelyx Latest Developments
Table 94. Naia Pharmaceuticals Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 96. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Naia Pharmaceuticals Main Business
Table 98. Naia Pharmaceuticals Latest Developments
Table 99. Nutrinia Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 101. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Nutrinia Main Business
Table 103. Nutrinia Latest Developments
Table 104. OxThera Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 106. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. OxThera Main Business
Table 108. OxThera Latest Developments
Table 109. Sancilio Pharmaceuticals Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 111. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Sancilio Pharmaceuticals Main Business
Table 113. Sancilio Pharmaceuticals Latest Developments
Table 114. Zealand Pharma Basic Information, Short Bowel Syndrome (SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolios and Specifications
Table 116. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Zealand Pharma Main Business
Table 118. Zealand Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Short Bowel Syndrome (SBS) Drugs
Figure 2. Short Bowel Syndrome (SBS) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Short Bowel Syndrome (SBS) Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country/Region (2024)
Figure 10. Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Glucagon-Like Peptide-2 (GLP-2)
Figure 12. Product Picture of Growth Hormone
Figure 13. Product Picture of Glutamine
Figure 14. Product Picture of Other
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type in 2025
Figure 16. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Short Bowel Syndrome (SBS) Drugs Consumed in Hospitals
Figure 18. Global Short Bowel Syndrome (SBS) Drugs Market: Hospitals (2020-2025) & (K Pcs)
Figure 19. Short Bowel Syndrome (SBS) Drugs Consumed in Clinics
Figure 20. Global Short Bowel Syndrome (SBS) Drugs Market: Clinics (2020-2025) & (K Pcs)
Figure 21. Short Bowel Syndrome (SBS) Drugs Consumed in Retail Pharmacies
Figure 22. Global Short Bowel Syndrome (SBS) Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
Figure 23. Global Short Bowel Syndrome (SBS) Drugs Sale Market Share by Sale Channel (2024)
Figure 24. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel in 2025
Figure 25. Short Bowel Syndrome (SBS) Drugs Sales by Company in 2025 (K Pcs)
Figure 26. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Company in 2025
Figure 27. Short Bowel Syndrome (SBS) Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Company in 2025
Figure 29. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 32. Americas Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 34. APAC Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 36. Europe Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2025
Figure 40. Americas Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 43. United States Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2025
Figure 48. APAC Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 51. China Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2025
Figure 59. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 62. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 70. Egypt Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Short Bowel Syndrome (SBS) Drugs in 2025
Figure 76. Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
Figure 77. Industry Chain Structure of Short Bowel Syndrome (SBS) Drugs
Figure 78. Channels of Distribution
Figure 79. Global Short Bowel Syndrome (SBS) Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Sale Channel (2026-2031)
Figure 84. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Sale Channel (2026-2031)
Figure 1. Picture of Short Bowel Syndrome (SBS) Drugs
Figure 2. Short Bowel Syndrome (SBS) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Short Bowel Syndrome (SBS) Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country/Region (2024)
Figure 10. Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Glucagon-Like Peptide-2 (GLP-2)
Figure 12. Product Picture of Growth Hormone
Figure 13. Product Picture of Glutamine
Figure 14. Product Picture of Other
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type in 2025
Figure 16. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Short Bowel Syndrome (SBS) Drugs Consumed in Hospitals
Figure 18. Global Short Bowel Syndrome (SBS) Drugs Market: Hospitals (2020-2025) & (K Pcs)
Figure 19. Short Bowel Syndrome (SBS) Drugs Consumed in Clinics
Figure 20. Global Short Bowel Syndrome (SBS) Drugs Market: Clinics (2020-2025) & (K Pcs)
Figure 21. Short Bowel Syndrome (SBS) Drugs Consumed in Retail Pharmacies
Figure 22. Global Short Bowel Syndrome (SBS) Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
Figure 23. Global Short Bowel Syndrome (SBS) Drugs Sale Market Share by Sale Channel (2024)
Figure 24. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel in 2025
Figure 25. Short Bowel Syndrome (SBS) Drugs Sales by Company in 2025 (K Pcs)
Figure 26. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Company in 2025
Figure 27. Short Bowel Syndrome (SBS) Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Company in 2025
Figure 29. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 32. Americas Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 34. APAC Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 36. Europe Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2025
Figure 40. Americas Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 43. United States Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2025
Figure 48. APAC Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 51. China Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country in 2025
Figure 59. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 62. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Figure 70. Egypt Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Short Bowel Syndrome (SBS) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Short Bowel Syndrome (SBS) Drugs in 2025
Figure 76. Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
Figure 77. Industry Chain Structure of Short Bowel Syndrome (SBS) Drugs
Figure 78. Channels of Distribution
Figure 79. Global Short Bowel Syndrome (SBS) Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Sale Channel (2026-2031)
Figure 84. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Sale Channel (2026-2031)
